Drugmakers partner with technology firms to develop new health IT tools
Pharmaceutical companies are seeking to collaborate with technology firms to develop new health IT tools that could improve clinical outcomes and reduce costs.
Biocon plunges into profit in the third quarter
Bangalore based biotechnology major Biocon has recorded a profit of 81 crores this quarter.
Wockhardt registers healthy growth in sales, operating margins and new acquisitions in ’08, but drags over MTM losses
Wockhardt Limited recently announced its financial results for ’08.
Wockhardt settles Entacapone patent and license agreement with Orion Corporation
Wockhardt Limited have uted the Entacapone patent settlement and license agreement with Orion Corporation in US.
“ICRI emphasises on highest standards of teaching” : Shiv Raman Dugal, Institute of Clinical Research India (ICRI)
Set up in 2004, Institute of Clinical Research India (ICRI) is known to be the country’s first premier institute exclusively focused on specialised Clinical Research education. Currently, ICRI has its presence in five Indian cities and is planning to set up a center in London.
“Clinical Research is a recession-proof industry” : Vijay Moza, CREMA – Clinical Research Education and Management Academy
CREMA – Clinical Research Education and Management Academy, is a premier training and research institute in Clinical and Biomedical studies. Launched in 2007 in Mumbai, it runs three campuses at Bengaluru, New Delhi and Hyderabad and plans to set up three more centers by the end of 2009. Last year CREMA started a full-time Advanced Post Graduate Ddiploma in Clinical Research.
Age old industry, new age education
[This article was published in the April 2009 issue of the eHEALTH Magazine (https://www.ehealthonline.org)]
In recent years, the buzzing Indian healthcare industry has generated a huge demand for manpower across many new skill areas and specialisations.
India’s first GMP compliant plasma fractionation facility
Celestial Biologicals Limited (CBL), an associated company of Intas Biopharmaceuticals Limited, and GE Healthcare, the USD 17 billion healthcare business of General Electric Company, announced recently a collaboration to set up India’s first Good Manufacturing Practice (GMP) compliant Plasma Fractionation facility in Ahmedabad.
20 more biotech parks to come up in India: Sibal
Union Minister of Science and Technology Kapil Sibal has announced 20 more biotech parks will be set up throughout the country for promoting research in the field of life sciences.
Bharat Biotech wins Orissa government
The Orissa Government has selected Bharat Biotech International (BBIL), as the
NEWS REVIEW – BUSINESS
[This article was published in the September 2008 issue of the eHEALTH Magazine (https://www.ehealthonline.org)]
Business News
Hindustan Latex to manufacture medical devices
Condom major Hindustan Latex Limited (HLL) has announced it will set up a MediPark near Chennai to manufacture diagnostic devices to boost the INR 25 billion medical devices market.
